Investigational drug (as of November 2002), a dual reuptake inhibitor for both serotonin and norepinephrine, being studied as an antidepressant and for control of pain and stress urinary incontinence.

Related categories 1

Cymbalta
Manufacturer's site for this selective serotonin and norepinephrine reuptake inhibitor (SSNRI), approved in the US to treat diabetic peripheral neuropathic pain and major depression.
Duloxetine Antidepressant Action Begins in One Week
Report on study findings announced in October 2002. [MedScape - Free registration required.]
MedlinePlus: Duloxetine
Features information about dosage, usage, warnings, and side effects.
[Davinci Mozilla]
Last update:
March 24, 2013 at 8:35:04 UTC
Health
Home
News
Recreation
Reference
Regional
Science
Shopping
Society
Sports
All Languages
Arts
Business
Computers
Games